Bicara Therapeutics Inc. (BCAX) Reports Q1 Loss of $0.68
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts BCAX Hot Sheet
Join SI Premium – FREE
Bicara Therapeutics Inc. (NASDAQ: BCAX) reported Q1 EPS of ($0.68), versus $0.00 reported last year.
For earnings history and earnings-related data on Bicara Therapeutics Inc. (BCAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arch Capital (ACGL) PT Raised to $106 at Keefe, Bruyette & Woods
- Adient (ADNT) 4300 contracts of November 17.50 calls trade
- U.S. officials held up approval for American chipmaking equipment needed by SK Hynix to expand China production - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
